ADMA Biologics ADMA Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's other income, net (note 6)?
- ADMA Biologics (ADMA) reported other income, net (note 6) of -$140K in Q1 2026.
- How has ADMA Biologics's other income, net (note 6) changed year-over-year?
- ADMA Biologics's other income, net (note 6) decreased by 118.8% year-over-year, from -$64K to -$140K.
- What is the long-term trend for ADMA Biologics's other income, net (note 6)?
- Over 4 years (2021 to 2025), ADMA Biologics's other income, net (note 6) has grown at a -4.5% compound annual growth rate (CAGR), from -$252K to -$210K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.